News Articles 151 - 160 of 160

Cancer Research UK - funding opportunities available to support clinical academic careers
News Type: BASL News

Cancer Research UK has a range of funding opportunities to support clinical academic careers. The upcoming deadlines are listed below against each scheme available:

Clinical Science Fellowship - offers excellent clinicians the opportunity to develop a research career through a period of postdoctoral training, including research abroad, over a period of 5 years. Next deadline: 24 October 2016.
For more information click > here.

Advanced Clinician Scientist Fellowship - allows clinicians to establish an independent research group alongside their clinical practice, over a period of 5 years. Next deadline: 24 October 2016.
For more information click > here.

Pre-doctoral Research Bursaries - provide short-term funding to allow clinicians and other health professionals to get involved in research projects early in their career. Next deadline: 6 September 2016.
For more information click here.

Postdoctoral Research Bursaries for Clinical Trainees - offer funding for clinical trainees to undertake a research project after completion of a PhD, during completion of their clinical specialty training. Next deadline: 6 September 2016.
For more information click here.

Please share the new details of these schemes with your networks or get in touch if you have any questions;

Hepatitis C Coalition - June Quarterly Newsletter
News Type: BASL News

Read the June Quartery edition of the Hepatitis C Coalition's newsletter > here.


NICE Clinical Guideline Updates Programme: Alcohol use disorder - Topic expert recruitment (22/06/16 - 20/07/16)
News Type: BASL News

NICE are looking for Topic experts to join their updates committee in updating the Alcohol use disorder: diagnosis and management of physical complications guideline.

They need both lay members (people using services, family members and carers, and members of the public and community or voluntary sector) and people with a professional or practitioner background in the topic.

The update will look at the following:
• In patients with acute alcohol-related hepatitis, what is the safety and efficacy of corticosteroids versus placebo?

They are therefore seeking to recruit the following experts:
• 3 x Hepatologists/Physicians
• 1 x Lay member
• 1 x Nurse specialist
• 1 x Pharmacist

To find out more visit the NICE website click > here to view the healthcare professional members advert and click > here to view the lay members advert. 

Both adverts will close 5pm on Wednesday 20th July 2016.

Please note that the key dates for meetings that must be attended are included in the advert – please take these into consideration when applying.

Dame Sheila Sherlock Research Prize – submit your application
News Type: BASL News

Submit your application for the Dame Sheila Sherlock Research Prize – deadline 09:00 hrs Monday 27th June 2016.

One of the highlights of the annual meeting this prize is awarded annually to recognise the enormous contribution of Dame Sheila Sherlock to the development of Hepatology as a discipline in its own right. In keeping with Dame Sheila’s enthusiasm for fostering young researchers, this eponymous research prize is awarded to young investigators without substantive posts in either medicine or science for their research contributions in the field of Hepatology.

The winner of the award will deliver a 20 minute lecture presenting their research during the Annual Meeting on Thursday 8th September 2016. This year the prize is free registration to the meeting, a place at the Annual Dinner and £1,000.

To apply, please send one A4 sheet outlining the research and another A4 sheet detailing the related publications.

Please send submissions to before the deadline of 09.00hrs Monday 27th June 2016.

BASL Committee Post Vacancies
News Type: BASL News

BASL are seeking nominations/ expressions of interest for two Committee posts.

Services Committee Chair
The Services Committee Chair – the chair is commissioned by the Governing Board to support the development and implementation of Clinical Standards and the provision of Clinical Services, including preparation and delivery of advice to national health authorities concerning liver diseases. The Services Committee Chair is elected by the membership to serve for a period of up to three years and may be re-elected once.

Paediatric representative
The Paediatric representative is appointed to represent the Paediatric Hepatology community across clinical standards of care, education, training and research. A current interest in Hepatitis C would be advantageous for the new post holder. The representative is elected by the membership to service for a period of up to three years.

Both post holders may be re-elected if they should choose to stand again.

Nomination Process
Candidates wishing to be considered for election will require one BASL member to propose them and a second member to confirm their suitability for the role in writing.

Please email Judy Hawksworth at the Secretariat with your nominations by 5 p.m. on Monday 20th June 2016. Following this time, candidate statements will be sought and voting will take place if necessary.

Article in Nature by AHA chair & colleagues - Alcohol: taking a population perspective
News Type: BASL News

 A paper has just been published in Nature by the chair of the Alcohol Health Alliance and colleagues making the case that improving public knowledge about alcohol harm will increase government appetite for regulation.

The paper, Alcohol: taking a population perspective, can be read in full > here

What is Liver QuEST?
News Type: BASL News

What is Liver QuEST?

Liver QuEST is a project that aims to improve the care of patients with liver disease. The ultimate aim is to provide an improvement and accreditation scheme for all liver services in the United Kingdom that will improve the care for patients with liver disease.

It asks services to improve themselves against 6 core standards (include hyperlink to standards):

1 Leadership and Organisation
2 Service Planning and Definition
3 Safety
4 Clinical Effectiveness
5 Person Centred Care
6 Staffing a Clinical Service

Services undergo self-assessment followed by peer review visits during the improvement process. The team conducting these visits include a patient, doctor, nurse and a quality assurance specialist. Ultimately the aim is for liver services to be accredited against these standards.

The project is funded by the Royal College of Physicians of London and has the backing of the patient groups, the British Society of Gastroenterology, The British Association for the Study of the Liver and the Lancet Commission.

A number of services are involved in the project and so far have visited 6 sites in the pilot stage. Two key themes emerged from the visits. Firstly most services were poor at demonstrating what services they provided and how to access them via the internet. Secondly units struggled to measure key performance indicators linked to the recently published cirrhosis care bundle, click here to view. 

Key performance indicators:

Antibiotic prescription in acute variceal bleeding 24 hrs either side of the procedure
Ascitic tap in emergency admissions with ascites (within 12 hours).
Albumin and Antibiotic prescription in patients diagnosed with SBP within 12 hours of diagnosis.
% of acute admissions with decompensated liver disease seen by a gastroenterologist/Hepatologist within 24 hours of admission.

A recent national meeting reviewed the project’s progress so far and was a great success. The plan is to roll the project out to more sites and utilise regional networks to promote Liver QuEST. The ultimate aim is to provide an improvement and accreditation scheme for all liver services in the United Kingdom that will improve the care for patients with liver disease.

Hepatitis C Coalition Quarterly Newsletter
News Type: BASL News

Click here to read the first edition of the Hepatitis C Coalition's quarterly newsletter, which provides a concise summary of developments in hepatitis C. Updates will be included from the Coalition’s diverse membership, which includes patient organisations, professional bodies, clinicians, industry and other interested parties.The newsletter provides a concise summary of news and policy developments in hepatitis C. 

AHA statement - Drink drive bill completes passage through the House of Lords
News Type: BASL News


Members of the House of Lords today passed a bill which would reduce the drink driving limit and save up to 100 lives a year – but it is unlikely to become law in the near future despite being supported by over 70% of the general public.

The Alcohol Health Alliance welcomed the vote to progress Lord Brooke’s drink driving bill beyond third reading. The vote means that the bill, which would amend the Road Traffic Act to lower the legal drink drive limit from 80mg alcohol per 100ml blood to 50mg/100ml, has now successfully completed all stages in the House of Lords.

Unfortunately, with little time remaining before the end of the Parliamentary term, there will not now be a chance for the bill to be considered on the floor of the House of Commons.

Professor Sir Ian Gilmore, chair of the Alcohol Health Alliance, said:
'We thank Lord Brooke for sponsoring this bill and for seeing its passage safely through the House of Lords. It is disappointing that there is no Parliamentary time for this bill to progress any further, but by championing this bill and making the evidence-based case for this change in the law, Lord Brooke has raised some very important issues, not least the fact that a reduction in the limit would save lives and prevent needless injury. We call on the government to now legislate to lower the drink drive limit'.

Lord Brooke or Alverthorpe, who won the Parliamentarian of the Month award in February by road safety charity Brake and Direct Line Group for his work on the bill, said:
'I welcome the support received from my Parliamentary colleagues in the Lords for this bill. Lowering the drink drive limit is consistently supported by the public, along with road traffic bodies, medical royal colleges and the emergency services, and all the evidence demonstrates that where the legal limit is lowered, deaths and casualties go down.

The only other country in Europe to have a drink drive limit as high as England and Wales is Malta, with every other European country setting the limit at 50mg or below. When Scotland lowered the limit, within the first nine months drink driving offences went down 12%, and Northern Ireland has just legislated to lower the limit. It can now only be a matter of time before the government takes notice of the evidence and levels of support for a lower legal limit, and legislates to lower the limit in England and Wales'.

About the Alcohol Health Alliance (AHA) - the AHA is a group of more than 40 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies. The AHA works together to:

· Highlight the rising levels of alcohol-related health harm
· Propose evidence-based solutions to reduce this harm
· Influence decision makers to take positive action to address the damage caused by alcohol misuse

For further information, please contact Matt Chorley, the AHA’s Policy and Communications Officer, at or on 0203 075 1726.

The Institute of Alcohol Studies Budget 2016 Analysis
News Type: BASL News

The Institute of Alcohol Studies has put together a briefing that summarises the decisions taken on alcohol in this year's Budget, and evaluates their likely impact. It also sets these policies in the context of recent history- following four years of real term cuts to duty: cheaper alcohol, lower Treasury revenues, increased illness and death, and no demonstrable benefits for pubs or exports.

To download the briefing please click here:  Download IAS Budget 2016 Analysis.pdf